Nutex Health (NASDAQ:NUTX) Shares Gap Down – Should You Sell?

Nutex Health Inc. (NASDAQ:NUTX) shares gapped down before the market opened on Monday . The stock had previously closed at $123.54, but opened at $120.00. Nutex Health shares last traded at $120.41, with a volume of 40,999 shares changing hands.

Wall Street Analysts Forecast Growth

Separately, Maxim Group boosted their target price on Nutex Health from $75.00 to $100.00 and gave the company a “buy” rating in a research note on Tuesday, April 8th.

Nutex Health Stock Performance

The firm has a market cap of $603.70 million, a P/E ratio of -11.57 and a beta of 0.27. The company has a quick ratio of 1.74, a current ratio of 1.77 and a debt-to-equity ratio of 3.36. The business has a fifty day simple moving average of $78.57 and a 200-day simple moving average of $50.48.

Nutex Health (NASDAQ:NUTX) last issued its quarterly earnings results on Monday, March 31st. The company reported $11.12 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.09) by $11.21. Nutex Health had a negative net margin of 14.09% and a negative return on equity of 51.27%. The company had revenue of $81.30 million during the quarter, compared to analysts’ expectations of $81.13 million.

Insider Buying and Selling

In other news, CFO Jon Christian Bates acquired 1,000 shares of the firm’s stock in a transaction that occurred on Tuesday, April 8th. The stock was bought at an average cost of $81.81 per share, for a total transaction of $81,810.00. Following the acquisition, the chief financial officer now directly owns 4,888 shares in the company, valued at approximately $399,887.28. The trade was a 25.72 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which can be accessed through this link. 38.52% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently modified their holdings of NUTX. Topline Capital Management LLC purchased a new stake in shares of Nutex Health during the 4th quarter valued at about $5,690,000. Essex Investment Management Co. LLC raised its stake in Nutex Health by 45.4% during the 4th quarter. Essex Investment Management Co. LLC now owns 105,809 shares of the company’s stock valued at $3,353,000 after buying an additional 33,024 shares during the last quarter. American Century Companies Inc. bought a new position in shares of Nutex Health during the 4th quarter valued at $1,362,000. Ancora Advisors LLC bought a new stake in shares of Nutex Health in the fourth quarter worth $1,334,000. Finally, Truist Financial Corp increased its position in Nutex Health by 22.2% during the fourth quarter. Truist Financial Corp now owns 35,570 shares of the company’s stock valued at $1,127,000 after acquiring an additional 6,454 shares during the last quarter. 5.32% of the stock is owned by institutional investors.

About Nutex Health

Nutex Health Inc operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management.